Semaglutide vs Sermorelin: Head-to-Head Comparison
Semaglutide and sermorelin approach weight/body composition from entirely different angles. Semaglutide suppresses appetite via GLP-1 receptors and is FDA-approved for obesity, while sermorelin stimulates GH release to improve body composition indirectly. Semaglutide has far stronger evidence for weight loss.
Side-by-Side Comparison
| Dimension | Semaglutide | Sermorelin |
|---|---|---|
| Evidence Level | Phase III trials, FDA-approved, massive real-world use | Previously FDA-approved for GH deficiency; off-label for body composition |
| FDA Status | FDA-approved for obesity and T2D | Previously FDA-approved (pediatric GH deficiency) |
| Mechanism | GLP-1 receptor agonist; appetite suppression, gastric slowing | GHRH analog; stimulates natural GH release |
| Weight Loss Efficacy | 15-17% body weight loss in trials | Modest body composition improvement via GH pathway |
| Side Effects | Nausea, vomiting, diarrhea, potential pancreatitis | Injection site reactions, headache, flushing |
| Cost | Very high ($1,000+/month branded) | Low to moderate (compounded) |
| Muscle Preservation | Significant lean mass loss reported | GH pathway may help preserve lean mass |
Peptide Overviews
Semaglutide
AFDA ApprovedSemaglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). One of the most studied peptide drugs in recent history.
Sermorelin
AFDA ApprovedSermorelin is the shortest fully functional fragment of GHRH (amino acids 1-29). It was the first GHRH analog approved by the FDA, marketed as Geref for diagnostic and therapeutic use.
Semaglutide vs Sermorelin: FAQ
Stay Informed on Peptide Research
Get weekly comparison updates, new study alerts, and regulatory changes.
No spam. Unsubscribe anytime.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.